25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CYAD (Celyad) Stock Analysis
Buy, Hold or Sell?

Let's analyze Celyad together

I guess you are interested in Celyad SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Celyad’s Financial Insights
  • 📈 Technical Analysis (TA) – Celyad’s Price Targets

I'm going to help you getting a better view of Celyad SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Celyad SA

I send you an email if I find something interesting about Celyad SA.

1. Quick Overview

1.1. Quick analysis of Celyad (30 sec.)










1.2. What can you expect buying and holding a share of Celyad? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.15
Expected worth in 1 year
€0.34
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
€0.19
Return On Investment
36.2%

For what price can you sell your share?

Current Price per Share
€0.53
Expected price per share
€0.4 - €0.661
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Celyad (5 min.)




Live pricePrice per Share (EOD)
€0.53
Intrinsic Value Per Share
€-5.42 - €-0.60
Total Value Per Share
€-5.27 - €-0.45

2.2. Growth of Celyad (5 min.)




Is Celyad growing?

Current yearPrevious yearGrowGrow %
How rich?$6.8m$4.6m$2.1m31.5%

How much money is Celyad making?

Current yearPrevious yearGrowGrow %
Making money-$9.1m-$44.2m$35.1m384.6%
Net Profit Margin-8,282.4%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Celyad (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#655 / 913

Most Revenue
#581 / 913

Most Profit
#426 / 913

Most Efficient
#849 / 913
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Celyad?

Welcome investor! Celyad's management wants to use your money to grow the business. In return you get a share of Celyad.

First you should know what it really means to hold a share of Celyad. And how you can make/lose money.

Speculation

The Price per Share of Celyad is €0.53. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Celyad.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Celyad, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.15. Based on the TTM, the Book Value Change Per Share is €0.05 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.95 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Celyad.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.22-41.6%-0.22-41.6%-1.07-201.7%-0.64-120.0%-0.74-140.3%
Usd Book Value Change Per Share0.059.8%0.059.8%-1.03-193.8%-0.26-48.6%-0.03-5.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.059.8%0.059.8%-1.03-193.8%-0.26-48.6%-0.03-5.2%
Usd Price Per Share0.42-0.42-0.55-4.49-18.62-
Price to Earnings Ratio-1.91--1.91--0.51--7.58--26.72-
Price-to-Total Gains Ratio8.13-8.13--0.53--7.99-14.36-
Price to Book Ratio2.56-2.56-4.86-5.68-14.97-
Price-to-Total Gains Ratio8.13-8.13--0.53--7.99-14.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.573513
Number of shares1743
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.05-0.26
Usd Total Gains Per Share0.05-0.26
Gains per Quarter (1743 shares)90.46-448.75
Gains per Year (1743 shares)361.84-1,795.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103623520-1795-1805
207247140-3590-3600
30108610760-5385-5395
40144714380-7180-7190
50180918000-8975-8985
60217121620-10770-10780
70253325240-12565-12575
80289528860-14360-14370
90325732480-16155-16165
100361836100-17950-17960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.014.00.00.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%5.05.00.050.0%7.07.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.014.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%5.05.00.050.0%7.07.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Celyad SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0480.0480%-0.949+2079%-0.238+596%-0.026+153%
Book Value Per Share--0.1520.1520%0.104+46%0.632-76%1.118-86%
Current Ratio--3.7933.7930%1.422+167%2.591+46%4.543-17%
Debt To Asset Ratio--0.6130.6130%0.781-22%0.574+7%0.471+30%
Debt To Equity Ratio--1.5831.5830%3.567-56%1.617-2%1.102+44%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--13183154.00013183154.0000%18008871.600-27%164781461.320-92%721445177.260-98%
Eps---0.204-0.2040%-0.988+385%-0.588+188%-0.687+237%
Ev To Ebitda Ratio---1.698-1.6980%-0.454-73%-7.679+352%-28.454+1576%
Ev To Sales Ratio--129.247129.2470%infnan%infnan%infnan%
Free Cash Flow Per Share---0.389-0.3890%-0.679+75%-0.618+59%-0.676+74%
Free Cash Flow To Equity Per Share---0.163-0.1630%-0.601+269%-0.252+55%-0.045-73%
Gross Profit Margin--1.0251.0250%1.006+2%1.019+1%1.021+0%
Intrinsic Value_10Y_max---0.604--------
Intrinsic Value_10Y_min---5.417--------
Intrinsic Value_1Y_max---0.464--------
Intrinsic Value_1Y_min---0.649--------
Intrinsic Value_3Y_max---1.086--------
Intrinsic Value_3Y_min---1.870--------
Intrinsic Value_5Y_max---1.338--------
Intrinsic Value_5Y_min---2.993--------
Market Cap21957158.000+26%16157154.00016157154.0000%20962871.600-23%171771261.320-91%712741777.260-98%
Net Profit Margin---82.824-82.8240%--100%-1671.005+1918%-1820.274+2098%
Operating Margin---83.892-83.8920%--100%-1693.938+1919%-1831.295+2083%
Operating Ratio--83.91283.9120%-+100%2045.842-96%2241.120-96%
Pb Ratio3.483+26%2.5632.5630%4.856-47%5.683-55%14.968-83%
Pe Ratio-2.599-36%-1.913-1.9130%-0.512-73%-7.579+296%-26.717+1297%
Price Per Share0.530+26%0.3900.3900%0.506-23%4.146-91%17.204-98%
Price To Free Cash Flow Ratio-1.364-36%-1.003-1.0030%-0.745-26%-6.175+515%-25.993+2490%
Price To Total Gains Ratio11.050+26%8.1318.1310%-0.533+107%-7.989+198%14.364-43%
Quick Ratio--2.5182.5180%1.314+92%2.246+12%4.909-49%
Return On Assets---0.519-0.5190%-2.076+300%-0.702+35%-0.535+3%
Return On Equity---1.340-1.3400%-9.482+608%-2.524+88%-1.560+16%
Total Gains Per Share--0.0480.0480%-0.949+2079%-0.238+596%-0.026+153%
Usd Book Value--6821558.4006821558.4000%4671425.700+46%28323534.660-76%50105341.980-86%
Usd Book Value Change Per Share--0.0520.0520%-1.027+2079%-0.257+596%-0.028+153%
Usd Book Value Per Share--0.1650.1650%0.113+46%0.684-76%1.209-86%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--14265490.94314265490.9430%19487399.958-27%178310019.294-92%780675826.313-98%
Usd Eps---0.221-0.2210%-1.069+385%-0.636+188%-0.744+237%
Usd Free Cash Flow---17422892.100-17422892.1000%-30442719.300+75%-27718640.760+59%-30316871.070+74%
Usd Free Cash Flow Per Share---0.421-0.4210%-0.735+75%-0.669+59%-0.732+74%
Usd Free Cash Flow To Equity Per Share---0.176-0.1760%-0.650+269%-0.273+55%-0.048-73%
Usd Market Cap23759840.672+26%17483656.34317483656.3430%22683923.358-23%185873681.874-91%771257877.173-98%
Usd Price Per Share0.574+26%0.4220.4220%0.548-23%4.487-91%18.617-98%
Usd Profit---9141580.800-9141580.8000%-44295763.500+385%-26409299.760+189%-30721792.890+236%
Usd Revenue--110374.200110374.2000%-+100%24455.460+351%1670762.400-93%
Usd Total Gains Per Share--0.0520.0520%-1.027+2079%-0.257+596%-0.028+153%
 EOD+6 -2MRQTTM+0 -0YOY+28 -95Y+26 -1110Y+19 -18

3.3 Fundamental Score

Let's check the fundamental score of Celyad SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.599
Price to Book Ratio (EOD)Between0-13.483
Net Profit Margin (MRQ)Greater than0-82.824
Operating Margin (MRQ)Greater than0-83.892
Quick Ratio (MRQ)Greater than12.518
Current Ratio (MRQ)Greater than13.793
Debt to Asset Ratio (MRQ)Less than10.613
Debt to Equity Ratio (MRQ)Less than11.583
Return on Equity (MRQ)Greater than0.15-1.340
Return on Assets (MRQ)Greater than0.05-0.519
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Celyad SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.453
Ma 20Greater thanMa 500.547
Ma 50Greater thanMa 1000.510
Ma 100Greater thanMa 2000.586
OpenGreater thanClose0.530
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Celyad SA

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Fundamental data was last updated by Penke on 2025-03-19 04:20:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Celyad earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • A Net Profit Margin of -8,282.4% means that €-82.82 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Celyad SA:

  • The MRQ is -8,282.4%. The company is making a huge loss. -2
  • The TTM is -8,282.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-8,282.4%TTM-8,282.4%0.0%
TTM-8,282.4%YOY--8,282.4%
TTM-8,282.4%5Y-167,100.5%+158,818.1%
5Y-167,100.5%10Y-182,027.4%+14,926.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,282.4%-109.6%-8,172.8%
TTM-8,282.4%-187.7%-8,094.7%
YOY--206.2%+206.2%
5Y-167,100.5%-404.0%-166,696.5%
10Y-182,027.4%-526.8%-181,500.6%
4.3.1.2. Return on Assets

Shows how efficient Celyad is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • -51.9% Return on Assets means that Celyad generated €-0.52 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Celyad SA:

  • The MRQ is -51.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -51.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.9%TTM-51.9%0.0%
TTM-51.9%YOY-207.6%+155.7%
TTM-51.9%5Y-70.2%+18.3%
5Y-70.2%10Y-53.5%-16.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.9%-14.4%-37.5%
TTM-51.9%-14.8%-37.1%
YOY-207.6%-14.6%-193.0%
5Y-70.2%-15.6%-54.6%
10Y-53.5%-18.0%-35.5%
4.3.1.3. Return on Equity

Shows how efficient Celyad is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • -134.0% Return on Equity means Celyad generated €-1.34 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Celyad SA:

  • The MRQ is -134.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -134.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-134.0%TTM-134.0%0.0%
TTM-134.0%YOY-948.2%+814.2%
TTM-134.0%5Y-252.4%+118.4%
5Y-252.4%10Y-156.0%-96.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-134.0%-17.7%-116.3%
TTM-134.0%-18.3%-115.7%
YOY-948.2%-19.2%-929.0%
5Y-252.4%-24.3%-228.1%
10Y-156.0%-26.3%-129.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Celyad SA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Celyad is operating .

  • Measures how much profit Celyad makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • An Operating Margin of -8,389.2% means the company generated €-83.89  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Celyad SA:

  • The MRQ is -8,389.2%. The company is operating very inefficient. -2
  • The TTM is -8,389.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8,389.2%TTM-8,389.2%0.0%
TTM-8,389.2%YOY--8,389.2%
TTM-8,389.2%5Y-169,393.8%+161,004.6%
5Y-169,393.8%10Y-183,129.5%+13,735.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,389.2%-224.0%-8,165.2%
TTM-8,389.2%-281.8%-8,107.4%
YOY--227.6%+227.6%
5Y-169,393.8%-398.6%-168,995.2%
10Y-183,129.5%-512.4%-182,617.1%
4.3.2.2. Operating Ratio

Measures how efficient Celyad is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 83.91 means that the operating costs are €83.91 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Celyad SA:

  • The MRQ is 83.912. The company is inefficient in keeping operating costs low. -1
  • The TTM is 83.912. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ83.912TTM83.9120.000
TTM83.912YOY-+83.912
TTM83.9125Y2,045.842-1,961.931
5Y2,045.84210Y2,241.120-195.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ83.9122.323+81.589
TTM83.9123.192+80.720
YOY-3.069-3.069
5Y2,045.8425.143+2,040.699
10Y2,241.1207.010+2,234.110
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Celyad SA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Celyad is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.79 means the company has €3.79 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Celyad SA:

  • The MRQ is 3.793. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.793. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.793TTM3.7930.000
TTM3.793YOY1.422+2.371
TTM3.7935Y2.591+1.202
5Y2.59110Y4.543-1.952
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7933.741+0.052
TTM3.7933.895-0.102
YOY1.4224.507-3.085
5Y2.5915.739-3.148
10Y4.5436.099-1.556
4.4.3.2. Quick Ratio

Measures if Celyad is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • A Quick Ratio of 2.52 means the company can pay off €2.52 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Celyad SA:

  • The MRQ is 2.518. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.518. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.518TTM2.5180.000
TTM2.518YOY1.314+1.204
TTM2.5185Y2.246+0.272
5Y2.24610Y4.909-2.662
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5183.086-0.568
TTM2.5183.326-0.808
YOY1.3144.362-3.048
5Y2.2465.726-3.480
10Y4.9096.427-1.518
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Celyad SA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Celyad assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Celyad to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.61 means that Celyad assets are financed with 61.3% credit (debt) and the remaining percentage (100% - 61.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Celyad SA:

  • The MRQ is 0.613. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.613. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.6130.000
TTM0.613YOY0.781-0.168
TTM0.6135Y0.574+0.039
5Y0.57410Y0.471+0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6130.340+0.273
TTM0.6130.340+0.273
YOY0.7810.314+0.467
5Y0.5740.365+0.209
10Y0.4710.392+0.079
4.5.4.2. Debt to Equity Ratio

Measures if Celyad is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • A Debt to Equity ratio of 158.3% means that company has €1.58 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Celyad SA:

  • The MRQ is 1.583. The company is just able to pay all its debts with equity.
  • The TTM is 1.583. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.583TTM1.5830.000
TTM1.583YOY3.567-1.984
TTM1.5835Y1.617-0.034
5Y1.61710Y1.102+0.515
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5830.399+1.184
TTM1.5830.407+1.176
YOY3.5670.384+3.183
5Y1.6170.426+1.191
10Y1.1020.460+0.642
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Celyad generates.

  • Above 15 is considered overpriced but always compare Celyad to the Biotechnology industry mean.
  • A PE ratio of -1.91 means the investor is paying €-1.91 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Celyad SA:

  • The EOD is -2.599. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.913. Based on the earnings, the company is expensive. -2
  • The TTM is -1.913. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.599MRQ-1.913-0.687
MRQ-1.913TTM-1.9130.000
TTM-1.913YOY-0.512-1.400
TTM-1.9135Y-7.579+5.666
5Y-7.57910Y-26.717+19.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.599-1.906-0.693
MRQ-1.913-2.688+0.775
TTM-1.913-3.245+1.332
YOY-0.512-3.240+2.728
5Y-7.579-6.333-1.246
10Y-26.717-7.137-19.580
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Celyad SA:

  • The EOD is -1.364. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.003. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.003. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.364MRQ-1.003-0.360
MRQ-1.003TTM-1.0030.000
TTM-1.003YOY-0.745-0.258
TTM-1.0035Y-6.175+5.172
5Y-6.17510Y-25.993+19.817
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.364-2.455+1.091
MRQ-1.003-3.724+2.721
TTM-1.003-4.254+3.251
YOY-0.745-4.356+3.611
5Y-6.175-8.511+2.336
10Y-25.993-9.739-16.254
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Celyad is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.56 means the investor is paying €2.56 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Celyad SA:

  • The EOD is 3.483. Based on the equity, the company is fair priced.
  • The MRQ is 2.563. Based on the equity, the company is underpriced. +1
  • The TTM is 2.563. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.483MRQ2.563+0.920
MRQ2.563TTM2.5630.000
TTM2.563YOY4.856-2.293
TTM2.5635Y5.683-3.120
5Y5.68310Y14.968-9.285
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.4831.726+1.757
MRQ2.5632.254+0.309
TTM2.5632.433+0.130
YOY4.8562.441+2.415
5Y5.6833.776+1.907
10Y14.9684.200+10.768
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets16,282
Total Liabilities9,978
Total Stockholder Equity6,304
 As reported
Total Liabilities 9,978
Total Stockholder Equity+ 6,304
Total Assets = 16,282

Assets

Total Assets16,282
Total Current Assets11,121
Long-term Assets5,161
Total Current Assets
Cash And Cash Equivalents 7,004
Net Receivables 380
Other Current Assets 3,737
Total Current Assets  (as reported)11,121
Total Current Assets  (calculated)11,121
+/-0
Long-term Assets
Property Plant Equipment 1,830
Goodwill 342
Intangible Assets 48
Long-term Assets Other 2,941
Long-term Assets  (as reported)5,161
Long-term Assets  (calculated)5,161
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,932
Long-term Liabilities7,046
Total Stockholder Equity6,304
Total Current Liabilities
Short-term Debt 156
Accounts payable 1,243
Other Current Liabilities 1,533
Total Current Liabilities  (as reported)2,932
Total Current Liabilities  (calculated)2,932
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)7,046
Long-term Liabilities  (calculated)0
+/- 7,046
Total Stockholder Equity
Common Stock32,949
Retained Earnings -358,372
Accumulated Other Comprehensive Income 331,727
Other Stockholders Equity 0
Total Stockholder Equity (as reported)6,304
Total Stockholder Equity (calculated)6,304
+/-0
Other
Cash and Short Term Investments 7,004
Common Stock Shares Outstanding 25,722
Current Deferred Revenue509
Liabilities and Stockholders Equity 16,282
Net Debt -5,946
Net Working Capital 8,189
Short Long Term Debt Total 1,058



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
17,495
6,877
13,746
32,386
43,976
159,525
138,805
77,626
94,299
89,836
66,084
79,943
19,716
16,282
16,28219,71679,94366,08489,83694,29977,626138,805159,52543,97632,38613,7466,87717,495
   > Total Current Assets 
6,476
3,469
2,192
22,602
32,935
109,419
85,367
36,394
51,692
42,836
19,705
34,292
14,825
11,121
11,12114,82534,29219,70542,83651,69236,39485,367109,41932,93522,6022,1923,4696,476
       Cash And Cash Equivalents 
3,827
1,751
1,645
19,058
27,633
100,175
48,357
23,253
40,542
39,338
17,234
30,018
12,445
7,004
7,00412,44530,01817,23439,33840,54223,25348,357100,17527,63319,0581,6451,7513,827
       Short-term Investments 
0
0
0
3,000
2,671
7,338
34,230
10,653
9,197
0
0
0
0
0
000009,19710,65334,2307,3382,6713,000000
       Net Receivables 
1,988
1,013
443
149
1,717
62
54
81
277
2,702
907
2,340
1,259
380
3801,2592,3409072,7022778154621,7171494431,0131,988
       Inventory 
360
0
-1,645
0
913
199
642
0
0
0
1,563
-2,137
0
-77
-770-2,1371,5630006421999130-1,6450360
       Other Current Assets 
301
1,802
249
123
2,600
544
2,726
2,559
1,676
796
2,076
1,934
1,121
3,737
3,7371,1211,9342,0767961,6762,5592,7265442,6001232491,802301
   > Long-term Assets 
11,019
3,408
11,554
9,783
11,041
50,105
53,440
41,232
42,607
47,000
46,379
45,651
4,891
5,161
5,1614,89145,65146,37947,00042,60741,23253,44050,10511,0419,78311,5543,40811,019
       Property Plant Equipment 
592
355
383
243
598
1,136
3,563
3,290
3,014
5,061
4,119
3,248
309
1,830
1,8303093,2484,1195,0613,0143,2903,5631,136598243383355592
       Goodwill 
0
0
0
0
0
1,003
1,040
914
883
883
883
883
0
342
34208838838838839141,0401,00300000
       Long Term Investments 
0
0
0
0
68
0
0
0
0
0
0
0
0
0
000000000680000
       Intangible Assets 
10,205
9,625
9,087
9,400
10,266
47,786
48,526
35,594
35,281
35,316
35,288
35,285
864
48
4886435,28535,28835,31635,28135,59448,52647,78610,2669,4009,0879,62510,205
       Long-term Assets Other 
222
183
151
140
109
180
311
1,434
3,429
5,740
6,089
6,235
3,718
2,941
2,9413,7186,2356,0895,7403,4291,434311180109140151183222
> Total Liabilities 
8,805
6,037
15,058
15,488
17,292
48,052
47,921
30,091
38,710
44,217
35,090
36,304
15,399
9,978
9,97815,39936,30435,09044,21738,71030,09147,92148,05217,29215,48815,0586,0378,805
   > Total Current Liabilities 
2,242
5,921
2,731
3,389
6,053
11,490
11,275
7,945
9,647
11,922
11,834
13,827
10,426
2,932
2,93210,42613,82711,83411,9229,6477,94511,27511,4906,0533,3892,7315,9212,242
       Short-term Debt 
291
0
408
79
134
248
561
636
765
1,359
1,113
902
137
156
1561379021,1131,359765636561248134794080291
       Short Long Term Debt 
0
0
0
106
413
976
207
209
281
192
37
0
0
0
00037192281209207976413106000
       Accounts payable 
1,287
1,086
1,770
2,169
4,042
8,576
8,098
4,800
5,916
6,969
4,736
6,611
4,752
1,243
1,2434,7526,6114,7366,9695,9164,8008,0988,5764,0422,1691,7701,0861,287
       Other Current Liabilities 
605
4,774
598
609
1,877
2,666
1,508
1,336
1,339
3,594
5,985
6,314
5,537
1,533
1,5335,5376,3145,9853,5941,3391,3361,5082,6661,8776095984,774605
   > Long-term Liabilities 
6,563
116
12,328
12,099
11,239
36,562
36,646
22,146
29,063
32,295
23,256
22,477
4,973
7,046
7,0464,97322,47723,25632,29529,06322,14636,64636,56211,23912,09912,3281166,563
       Long term Debt Total 
0
0
0
0
0
427
917
808
881
3,004
0
0
0
0
00003,00488180891742700000
       Long term Debt 
243
116
109
27
279
427
536
326
229
37
0
0
0
0
00003722932653642727927109116243
       Capital Lease Obligations 
0
0
0
0
0
0
735
909
1,136
4,134
3,601
2,632
255
0
02552,6323,6014,1341,136909735000000
       Other Liabilities 
6,320
7,847
11,157
12,072
10,960
36,135
35,729
21,338
28,180
29,291
20,731
20,747
4,855
0
04,85520,74720,73129,29128,18021,33835,72936,13510,96012,07211,1577,8476,320
       Long-term Liabilities Other 
0
0
0
0
0
0
28,195
19,590
25,187
0
371
164
258
0
0258164371025,18719,59028,195000000
       Deferred Long Term Liability 
0
0
0
925
911
872
805
739
673
607
541
474
408
0
0408474541607673739805872911925000
> Total Stockholder Equity
8,690
840
-1,312
16,898
26,684
111,473
90,884
47,535
55,591
45,619
30,994
43,639
4,317
6,304
6,3044,31743,63930,99445,61955,59147,53590,884111,47326,68416,898-1,3128408,690
   Common Stock
28,900
9,975
9,975
22,138
24,615
32,571
32,571
34,337
41,553
48,513
48,513
78,585
78,585
32,949
32,94978,58578,58548,51348,51341,55334,33732,57132,57124,61522,1389,9759,97528,900
   Retained Earnings -358,372-349,947-308,997-91,826-74,424-217,778-180,421-124,026-100,313-71,215-36,388-11,287-9,134-20,694
   Accumulated Other Comprehensive Income 
484
0
0
-1,872
19,982
21,205
24,329
23,322
25,667
28,181
30,958
267,734
269,362
331,727
331,727269,362267,73430,95828,18125,66723,32224,32921,20519,982-1,87200484
   Capital Surplus 
0
0
0
0
0
158,010
158,010
170,297
206,149
43,349
0
0
0
0
000043,349206,149170,297158,010158,01000000
   Treasury Stock00000000000000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue102
Cost of Revenue-69
Gross Profit3333
 
Operating Income (+$)
Gross Profit33
Operating Expense-8,490
Operating Income-8,457-8,457
 
Operating Expense (+$)
Research Development4,668
Selling General Administrative5,707
Selling And Marketing Expenses215
Operating Expense8,49010,590
 
Net Interest Income (+$)
Interest Income0
Interest Expense-84
Other Finance Cost-84
Net Interest Income0
 
Pretax Income (+$)
Operating Income-8,457
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,511-8,403
EBIT - interestExpense = -8,641
-8,639
-8,364
Interest Expense84
Earnings Before Interest and Taxes (EBIT)-8,557-8,427
Earnings Before Interest and Taxes (EBITDA)-7,763
 
After tax Income (+$)
Income Before Tax-8,511
Tax Provision-0
Net Income From Continuing Ops0-8,511
Net Income-8,448
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,559
Total Other Income/Expenses Net-540
 

Technical Analysis of Celyad
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Celyad. The general trend of Celyad is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Celyad's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Celyad Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Celyad SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.637 < 0.65 < 0.661.

The bearish price targets are: 0.45 > 0.41 > 0.4.

Know someone who trades $CYAD? Share this with them.👇

Celyad SA Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Celyad SA. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Celyad SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Celyad SA. The current macd is 0.0068225.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Celyad price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Celyad. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Celyad price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Celyad SA Daily Moving Average Convergence/Divergence (MACD) ChartCelyad SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Celyad SA. The current adx is 38.74.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Celyad shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Celyad SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Celyad SA. The current sar is 0.68212955.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Celyad SA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Celyad SA. The current rsi is 47.45. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Celyad SA Daily Relative Strength Index (RSI) ChartCelyad SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Celyad SA. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Celyad price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Celyad SA Daily Stochastic Oscillator ChartCelyad SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Celyad SA. The current cci is -23.43403022.

Celyad SA Daily Commodity Channel Index (CCI) ChartCelyad SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Celyad SA. The current cmo is -13.89347488.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Celyad SA Daily Chande Momentum Oscillator (CMO) ChartCelyad SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Celyad SA. The current willr is -85.71428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Celyad SA Daily Williams %R ChartCelyad SA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Celyad SA.

Celyad SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Celyad SA. The current atr is 0.05225051.

Celyad SA Daily Average True Range (ATR) ChartCelyad SA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Celyad SA. The current obv is 1,689,287.

Celyad SA Daily On-Balance Volume (OBV) ChartCelyad SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Celyad SA. The current mfi is 68.75.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Celyad SA Daily Money Flow Index (MFI) ChartCelyad SA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Celyad SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Celyad SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Celyad SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.453
Ma 20Greater thanMa 500.547
Ma 50Greater thanMa 1000.510
Ma 100Greater thanMa 2000.586
OpenGreater thanClose0.530
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Celyad with someone you think should read this too:
  • Are you bullish or bearish on Celyad? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Celyad? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Celyad SA

I send you an email if I find something interesting about Celyad SA.


Comments

How you think about this?

Leave a comment

Stay informed about Celyad SA.

Receive notifications about Celyad SA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.